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1. Introduction 
Inflammation is usually defined as a complex response of the animal organism to tissue 
injury or to invasion of foreign pathogens. Although inflammation often starts as a local 
reaction it can easily develop into a generalized systemic response involving the whole 
organism. Participation of inflammatory reactions in the pathogenesis of many diseases is 
today a generally accepted medical paradigm. These ideas have been thoroughly discussed 
in numerous excellent monographs and specialized recent publications (Nathan, 2002; 
Dinarello, 2008, 2010; Medzhitov, 2010) whereas our presentation is just a brief account 
focused on regulatory mechanisms involved in the initiation, development and termination 
of the “generalized inflammatory response” (GIR) and its relations to the induced synthesis 
of certain plasma and tissue proteins. 
The results obtained by techniques of modern genomics indicate that these three phases of 
response to injury are tightly controlled and are characterized by distinct profiles of 
hundreds of activated genes. The fine tuning of gene expression during initiation, 
development and resolution of inflammation occurs at many levels starting from 
transcription and followed by changes in mRNA decay, receptors cross-talk, intracellular 
signaling cascades and posttranslational protein modifications. Disturbances in the 
regulatory network lead to either acute pathological states  such as septic shock, or to 
various chronic autoimmune and auto-inflammatory diseases. 
Discovery of C-reactive protein (CRP) in the blood of patients with febrile diseases some 80 
years ago (Tillett & Francis, 1930) was seminal for the development of the idea of  “acute 
phase reaction” (APR) and the concept of “acute phase proteins” (APPs) reflected as 
profound rearrangement of plasma protein profile accompanying systemic inflammatory 
reaction (Kushner, 1982). The so called “positive AP-proteins” increase their  plasma 
concentration  in a broad range – from barely 25 per cent above the control  up to several 
hundred fold - at the expense of “negative APPs” which go down in comparison to control. 
Other metabolic changes during this response include fever, leukocytosis, negative nitrogen 
balance, altered levels of some ions and hormones, activation of clotting and complement 
pathways, as well as certain less defined phenomena (for references see (Gordon and Koj, 
1985)). The principal features of APR resemble the unspecific innate immunological reaction 
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and some authors assume that in fact we are dealing with synonyms corresponding to the 
two sides of the same biological phenomenon (Koj, 2008). From historic perspective 
however, the APR corresponds to the metabolic response of liver, manifested 
predominantly as induced synthesis of acute phase proteins. For several years it was silently 
assumed that the term APP is limited to plasma proteins synthesized by and secreted from 
liver parenchymal cells. However, many resident proteins are also affected by inflammatory 
response and they are called “acute phase regulated intracellular proteins” i.e. APRIPs 
(Ruminy et al., 2001), or even more broadly – cytokine-responsive cellular proteins (Koj, 
2008).  
2. Initiation of generalized inflammatory response 
Inflammation can be induced by two types of noxious stimuli: invasion of foreign pathogens 
of biological origin, or sterile tissue damage. In reality, however, the most common is mixed 
type of GIR. The pathogens include bacteria, fungi, yeasts, viruses or parasites as well as their 
products which after penetrating of the organism are present either in the extracellular space, 
or already in the cell compartments. In the first case they can be recognized by a special class 
of cell membrane receptors abounding on the surface of sentinel cells exposed to the 
environment. Receptors of this type were first discovered in Drosophila fruit fly and named 
Toll receptors, being important for embryonic development and protection against invading 
fungi. Their mammalian counterparts named Toll-like receptors (TLRs) have been extensively 
studied during last 15 years (Medzhitov et al., 1997). TLRs are able to discriminate between 
self and non-self by recognizing pathogen-associated molecular patterns (PAMPs) 
(Medzhitov, 2010). Typical examples of this class of PAMPs  are lipopolysaccharides of the 
bacterial wall, or mannans from the yeasts cells (Takeuchi & Akira, 2010). Today more than ten 
mammalian TLRs are known and depending on their cellular localization and type of the 
ligand they are divided into two subgroups.  TLRs from the first group are localized at the cell 
membrane (TLRs 1, 2, 4, 5, 6, 10), whereas others (TLRs 3, 7, 8, 9) are expressed intracellularly 
anchoring vesicles of the  endoplasmic reticulum, endosomes and lysosomes (Kawai & Akira, 
2010; Ospelt & Gay, 2010). Toll-like receptors are important in the initiation of molecular alarm 
during pathogen invasion of the host and also in response to other danger signals expressed in 
a variety of immune as well as non-immune cells. Effector or “sentinel” cells, such as 
neutrophils, dendritic cells and macrophages express almost all types of TLRs, in distinction to 
other specialized cells. The first group of TLRs recognizes mainly microbial membrane 
components (lipids, lipoproteins and proteins) whereas the other group responds to microbial 
nucleic acids. For example TLR1 acts mainly as a heterodimer together with TLR2 and 
recognizes lipopeptides originating from Mycobacteria. TLR2 responds also to material derived 
from bacteria, fungi, parasites and viruses (lipopeptides, peptidoglycan, lipoarabinomannan, 
zymosan  or hemagglutinins), whereas the heterodimer TLR2/TLR6 binds lipopeptides. TLR4 
was the first TLR identified in human cells and we know that it responds to bacterial 
lipopolysaccharides (LPS) from the membrane of Gram-negative bacteria (Akira et al., 2006). 
Another receptor from this group, TLR5, recognizes bacterial protein, flagellin, essential for 
movement of bacteria (Akira et al., 2006). The recently discovered human TLR10 was found to 
heterodimerize with TLR1 (Hasan et al., 2005) but so far its ligand was not determined. As 
already mentioned, TLRs from intracellular compartments may recognize nucleic acids: TLR3 
binds double stranded RNA of viral origin, but also similar endogenous ligands from necrotic 
cells (Brentano et al., 2005). On the other hand, TLR7 and TLR8 respond to single-stranded 
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RNA from viruses and endogenous sources. Finally, TLR9 recognizes DNA-containing 
unmethylated CpG motifs. All the discussed TLRs differ not only in structure and ligand 
affinity but also in the intracellular signaling cascades. Their ability to form dimers certainly 
expands the array of recognized PAMPs. Signals generated by the formation of a PAMP-TLR 
complex activate at least one out of five specific adaptor cytoplasmic proteins (MyD88, MAL, 
TRIF, TRAF or SARM) (O’Neill & Bowie, 2007). These adaptors participate in transmission of a 
message from the plasma membrane through a multi-step cascade to a responsive 
transcription factor – NF-κB being the principal target (Fig.1). 
 
 
Fig. 1. Scheme of initiation and development of inflammatory response.  For abbreviations 
used and for further detail see the text. 
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However, some pathogen-derived molecules, such as foreign DNA or RNA, may reach 
intracellular compartments of infected cells where they are recognized by and bound to 
NOD-like receptors (NLRs) (Akira et al., 2006; Ye & Ting,  2008).  The NLRs belong to a 
large family of cytosolic pattern recognition receptors (34 members in mice, 23 in human) 
(Jin & Flawell, 2010) that are able to recognize various pathogen associated molecular 
patterns or danger-associated molecular patterns and thereby initiate the innate immune 
response against invading pathogens and cellular signals of damage or stress.  
These NLRs, multi-domain  receptor proteins, are characterized by leucine-reach repeats 
(LRRs) at the C-terminal region, a central nucleotide binding and oligomerization domain 
(referred to as NOD domain), toward N-terminal effector domain. From evolutionary point 
of view it is very interesting that animal NLRs show certain similarities to the products of 
plant disease-resistant genes (Martinon et al., 2009). Some NLRs act just as receptors while 
other constitute components of specialized cytosolic structures – inflammasomes (Schroder 
& Tschopp, 2010; Martinon et al., 2009). Certain NLRs interact with the ubiquitin ligase-
associated protein SGT1 and HSP90, and this leads to the inhibition of inflammasome 
activity  (Mayor et al. 2007).  
In comparison to pathogen induced response the signaling elicited by pathogen-free tissue 
injury is even more complex and includes various DAMPs (damage-associated molecular 
patterns) such as crystals of uric acid or cholesterol (responsible for symptoms of gout or 
atherosclerosis) (Rock et al., 2010), fibers of asbestos and grains of silica (accumulated in 
lungs in asbestosis and silicosis) (Martinon et al., 2009; Rock et al., 2010), chemical irritants 
such as turpentine oil (Sheikh et al., 2007), deposits of denatured or modified proteins (such 
as inactivated alpha-1-proteinase inhibitor) (Koj & Guzdek, 1995), or fibrillar amyloid beta 
peptide found in the brain in Alzheimer disease (Halle et al., 2008). But commonly occurring 
pathogen-free tissue damage leading to inflammation can be also elicited by extreme 
temperatures, by hypo- or hyperosmolarity (Shapiro & Dinarello, 1997; Bode et al., 1999), by 
hypoxia-reoxygenation process (Wenger et al., 1995), UV radiation (Feldmeyer et al., (2007) 
and accumulation of reactive oxygen species (Bogdan et al., 2000). These signals may - by 
various means - stimulate cells either through specialized appropriate Toll-like receptors 
(Takeuchi & Akira, 2010) or certain scavenger receptors, or using other sensitive 
intracellular surveillance molecules, such as plasma membrane transporters (Schroder and 
Tchopp, 2010) or activation of MAP kinases (Bode et al., 1999; Chang & Karin, 2001). The use 
of alternative signaling routes occurs in case of hypoxia which is known to mobilize a 
specific transcription factor HIF-1 and proline hydroxylases (Zagorska & Dulak 2004; Oliver 
et al., 2009). 
Usually the multi-step signaling cascade activated by pathogen-free tissue injury (or by 
stress of environmental origin) merges at some stage with the cascade initiated by foreign 
pathogens resulting  in activation of transcription factors, among which the most important 
is NF-κB (Fig.1). This leads to a prompt transcription of sensitive genes resulting in 
accumulation of specific mRNAs coding mainly for IL-1ǃ and other cytokines involved in 
the development of inflammation. It is understood now that translation of some of these 
mRNAs into active proteins may require an additional signal as it was earlier found in the 
case of IL-1ǃ (Dinarello, 1996); if this signal is missing, initiation of the inflammatory 
response may be delayed or entirely aborted.  
In order to briefly recapitulate current views on the initiation of inflammatory reaction one 
should emphasize the importance of signals indicating imminent danger to the 
cell/organism. Their detection is based on the ability of cells to recognize such signals by a 
small number of germline-encoded Pattern Recognition Receptors (PRRs). These PRRs are 
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able to discriminate between self and non-self of certain molecular structures that may 
appear either outside of the cell (e.g. bacterial LPS is bound to Toll-like receptors located on 
the cell membrane), or are found intracellularly (e.g. foreign DNA or RNA in the cytosol) 
where they are recognized by NOD-like receptors (NLRs). However, PRRs can be 
stimulated not only by binding Pathogen Associated Molecular Patterns (PAMPs) but also 
by host own stress and danger signals (SAMPs and DAMPs) derived from damaged cells. 
These signals are recognized by cytosolic, intracellular receptors, among which the most 
important are NLRs. Moreover, some NLRs are used for the construction of specialized 
subcellular structures – inflammasomes – serving as the activation platform for the key pro-
inflammatory  cytokine – IL-1ǃ. 
3. The role of inflammasomes 
Undoubtedly, IL-1ǃ is the key mediator in the host innate response to infection and the 
driving force in the development of inflammation. However, since IL-1ǃ is synthesized as a 
leaderless pro-cytokine it must be processed for secretion and exhibition of biological 
activity (similar properties are shown also by IL-18 and IL-33) (Dinarello, 1996, 2008, 2010). 
The proteolytic activation of pro-IL-1ǃ is accomplished by an enzyme initially named ICE 
(Interleukin-1-converting enzyme) but at present known as caspase-1 belonging to the 
family of cysteine-aspartyl proteases participating in apoptosis. Caspase-1 is synthesized as 
zymogen which undergoes autocatalytic processing. Only relatively recently it has been 
established that efficient activation of pro-caspase-1 and pro-IL-1ǃ takes place in specialized 
cytoplasmic multiprotein platforms called inflammasomes (Dinarello, 2008; Martinon et al., 
2009; Schroder & Tschopp, 2010).  
As discussed by Martinon et al. (2009), the details of inflammasome structure are only partly 
revealed but several types of molecules can be distinguished. The best known NLRP3 
inflammasome (alternative names – NALP3 or cryopyrin) includes NLRP3 protein which 
interacts with the adaptor protein ASC (apoptosis-associated speck-like protein with a 
caspase recruitment domain). The resulting complex binds and activates pro-caspase-1 to 
caspase-1 which in turn is ready to activate pro-IL-1ǃ (Fig.2). It appears that activation of 
caspase-1 requires zinc and is dependent on pannexin-1, a protein localized upstream in this 
signaling cascade  (Brough et al., 2009). 
Assembly and activation of inflammasome can be induced by several factors discussed 
above, but recent review presented by Martinon et al., (2009) enlarges this list to include 
various signals of danger and stress (DAMPs or SAMPs). Extracellular ATP represents such 
a stress signal released locally and recognized by a specific purinergic receptor P2X7  (Ferrari 
et al., 2006; Lister et al., 2007).  
Charles Dinarello was probably first to report that in order to obtain active and mature IL-
1ǃ molecules two independent cellular signals are required for effective transcription and 
translation (Dinarello, 1996). When studying activation of NLRP3 inflammasome 
Bauernfeind et al., (2009) observed that this process also needs two signals: one provided by 
the NF-κB cascade is necessary but not sufficient, whereas the second signal is generated by 
extracellular ATP, or crystal-induced cell damage. Other inducers of inflammasome 
assembly include such widely different factors as reactive oxygen intermediates, products of 
lysosomal damage and leakage of potassium from the cell (Martinon et al., 2009; Rock et al., 
2010). We know today that the inflammasome may act as a sensor of the oxidative stress by 
co-operation  with thioredoxin (Jin & Flavell, 2010; Zhou et al., 2010). The broad spectrum of 
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modulators of inflammasome assembly and activation confirms the importance of these 
subcellular structures that are just being recognized as new targets in the anti-inflammatory 
therapies (Stehlik & Dorfleutner, 2007; Lamkanfi et al., 2009; Dinarello, 2010; Martinon et al., 
2010; Rock et al., 2010). 
 
 
Fig. 2. Principal domains of NLRP1 protein (A) and schematic function of NLRP3 
inflammasome  (B). 
The drawings are based on the data of Agostini et al., (2004); Dinarello, (2008) and Martinon 
et al. (2009). PYD, pyrin domain; NACHT, central nucleotide binding and oligomerization 
domain; NAD, NACHT-associated domain; LRR, leucine-rich repeats; FIIND, domain of 
poorly defined function; CARD, caspase recruitment domain; ASC, apoptosis speck-like 
protein adjacent to  CARD at C-terminal where pro-caspase is initially located.  
4. Inflammation control: components and rules  
Local inflammation can be transformed within a few hours into a life-threatening 
generalized inflammatory response and thus the development of mechanisms controlling its 
course is of prime importance. The list of main players in the field of inflammation 
development and control is shown in Table 1, but their detailed analysis is beyond the scope 
of this brief review. The data obtained by techniques of functional genomics indicate that 
several hundreds of genes participate in the inflammatory response and their coordinated 
expression is tightly regulated (for references see Koj, 2008; Jura et al., 2008). These genes 
can be grouped into subsets as coding for various transcription factors, cytokines, 
chemokines, interferons, cellular growth factors and corresponding receptors, as well as 
those coding for adhesion molecules and enzymes involved in the production and removal 
of free radicals, or in modification of newly synthesized polypeptide chains by glycosylation 
or phosphorylation. 
Most of these genes and their products share some striking features concerning the 
mechanism of biosynthesis and degradation of inflammatory mediators, and especially of 
cytokines: 
 Promoters of these genes often contain multiple binding sites for several transcription 
factors (TFs): the most important being NF-κB. Its activation can be achieved in several 
independent signaling cascades, one of them - induced by LPS – being shown in Fig. 3. 
However, NF-κB is more than just a transcription factor and should be rather regarded 
as an universal switch in the innate and acquired immune reactions (reviewed in  
Hoffmann & Baltimore, 2006). Other typical transcription factors used  by inflammatory 
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mediators include AP-1, (activator protein-1, usually a hetero-dimer of c-Fos/c-Jun 
(Hattori et al., 1993)), STAT (signal transducer and activator of transcription known in 
six isoforms numbered STAT1 – STAT6 (Baumann, 2003; Heinrich et al., 2003; Sehgal, 
2008), C/EBP (CAAT enhancer binding protein, occurring in four isoforms (Huang & 
Liao, 1994) and Elk-1 (Kasza et al., 2010) (for comprehensive list of earlier references see 
Ray et al., 1990; Koj, 1996, Ruminy et al., 2001). The interactions between the various 
TFs that compete for binding sites in the promoter regions of various genes are highly 
complex and regulation of  IL-6 expression, described first by Sehgal et al., (1995) and 
later by van den Berghe et al., (2000), may provide some useful information. 
 
 
Fig. 3. Simplified scheme of a signaling pathway activated by bacterial endotoxin (LPS). 
LPS (1) interacts with LPS-binding protein (2) and with help of plasma membrane receptor CD14 (3) is 
transferred to Toll-like receptor TLR4 (5) which requires MD2 accessory protein (4). Activation of TLR4 
leads to the recruitment of an adaptor protein MyD88 with subsequent involvement of several adaptor 
or enzymatic proteins (some of them not shown on the scheme): Tollip, IRAK (IL-1R-Associated Kinase) 
and TRAF (TNF-Receptor Associated Factor). IRAK4 is phosphorylated and activates IRAK1, which in 
turn interacts with TNF receptor-associated factor 6 (TRAF6) complex causing its oligomerization and 
activation. Proteins from TRAF6 complex activate IKK and MAP kinases (ERK1/3, JNK, p38). IKK is a 
complex of two protein kinase subunits, IKKalfa and IKKbeta, and a regulatory subunit IKKgamma 
(NEMO). Activation of IKK complex leads to phosphorylation of NF-κB inhibitor (IkB) and its 
degradation, resulting finally in the release of NF-κB and its translocation to the nucleus. AP-1 
(Activator protein-1) is another transcription factor activated by this cascade. 
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 The half-life of mRNAs coding for mediators of inflammation is considerably shorter 
than that of mRNAs of various housekeeping genes (Sharova et al., 2009). The short-
lived mRNAs were found to possess (usually in the 3’untranslated regions) AU-rich 
elements (ARE) recognized by specific proteins that are able to destabilize mRNA and 
deliver it to the cellular sites of degradation: exosomes and/or processing bodies (P-
bodies) (Chen et al., 2001;  Garneau et al., 2007; Eulalio et al., 2007).  The list of ARE-
binding proteins involved in mRNA decay includes  tristetraprolin (Stoecklin et al., 
2004), AUF-1 and AUF-2, (Lu et al., 2006)  TIA-1 and TIAR (Dean et al., 2004), KSRP 
(Gherzi et al., 2007) and HuR (Dean et al., 2004). This last protein (HuR) acts in a rather 
unusual way since it stabilizes mRNA and prolongs its life in the cell.  On the other 
hand, macrophage chemotactic protein-induced protein-1 (MCPIP1), studied also in our 
laboratory (Mizgalska et al,. 2009; Skalniak et al., 2009), is able to degrade mRNAs 
coding for IL-1ǃ, IL-6 and IL-12p40 (but not for TNFalpha), although it does not require 
the ARE signal (Matsushita et al., 2009; Mizgalska et al., 2009) 
 Finally, the majority of proteins involved in the control of inflammatory response 
exhibit short half-lives being susceptible to degradation in a proteasome after initial 
ubiquitination (for references see Evans, 2005). 
This variable length of life and a fast turnover of mediators of inflammation, achieved either  at 
the stage of their mRNA or mature protein, permit for elastic control and fine regulation of 
inflammatory reactions. An additional mechanism used for the tuning of some inflammatory 
pathways depends on transient phosphorylation of susceptible proteins by kinases from the 
MAP family (Herlaar & Brown, 1999). According to Chang and Karin (2001) mammals express 
at least four distinctly regulated groups of mitogen activated protein kinases able to 
phosphorylate serine-threonine residues: Jun amino-terminal kinases (JNK), p38 proteins in 
four isoforms, and two groups of extracellular signal-regulated kinases (ERKs).  The 
representatives of all groups participate in regulation of inflammatory mediators, usually in a 
multi-step cascade reactions. These cascades may stretch  from cell membrane receptors to 
transcription factors in the cell nucleus; moreover, some of MAP kinases fulfill the role of 
cellular sensors directly responding to chemical and physical stresses (Chang & Karin, 2001). 
According to Winzen et al (1999) p38 MAP kinase contributes to cytokine- or stress-induced 
gene expression by stabilizing mRNAs through ARE-targeted mechanism. The central role of 
p38 MAPK in the early transcriptional responses to various types of stress has been confirmed 
in the recent studies discussed by Cuenda & Rousseau (2007) and Whitmarsh (2010). However, 
since  disorganized cytokine signal transduction may have disastrous consequences so the 
action of protein kinases is monitored  by protein phosphatases containing SH2 domain (Src 
homology 2 domain). Still this is not always sufficient and specific proteins (PIAS) inhibiting 
activated STATs have evolved  (Wormald & Hilton, 2003). 
Table 1 shows arbitrary assignment of many components: e.g. IL-6 family has not only 
proinflammatory but also some anti-inflammatory properties depending on the stage of 
inflammation (Scheller et al., 2011); the IL-1 family includes at least 11 separate proteins; 
VEGF is usually regarded as vascular endothelial growth factor but at the same time it 
shows strong pro-inflammatory activity. Leukotriene LTB4 stimulates migration of 
leukocytes but this effect is inhibited by lipoxin LXB4 (Conti et al., 1991).  
5. Resolution of inflammation and termination of acute phase response 
After the injury-elicited initiation of inflammatory reaction followed by fully developed 
inflammatory response the resolution phase is expected. In reality, however, this scheme is 
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not always observed and at least three different results are possible: (a) acute illness with a 
fatal outcome; (b) prolonged chronic disease; (c) prompt return to health after a period of 
reconvalescence. 
a. When overproduction of proinflammatory mediatiors continues and negative effects of 
injury prevail, the generalized systemic inflammatory response may exceed the 
programmed limits of organism defense resulting in death. Such situations occur 
during the acute septic shock syndrome which is extremely resistant to medical 
treatment and death is caused not only by invading pathogens but often results from 
the excess of  certain cytokines participating in the multiorgan failure (for references see 
Herzum & Renz, 2008).   
b. When invading pathogens, or other injuring factors, continue their action on the 
organism but a transient equilibrium is achieved, the development of a chronic 
inflammatory disease, such as rheumatoid arthritis, may occur. Taking into account 
various mechanisms of molecular pathology, chronic inflammatory diseases are being 
currently divided into two separate groups: autoimmune (Zenewicz et al., 2010) and 
auto-inflammatory ones (Kastner et al., 2010). The first group includes rheumatoid 
arthritis, inflammatory bowel disease (Crohn disease), type 1 diabetes, psoriasis, lupus 
erythematosus and multiple sclerosis, and is regarded as dysfunction of T-cells. By 
contrast, the autoinflammatory diseases are caused by dysfunctional macrophages 
producing excesive amounts of IL-1beta. Typical examples of autoinflammatory 
diseases are: type 2 diabetes, cryopyrin-associated periodic syndromes (e.g. familial 
cold autoinflammatory syndrome, Muckle-Wells syndrome) and neonatal onset of 
multiinflammatory disease. These disorders respond well to the treatment aimed at 
limiting synthesis and release of IL-1beta (Dinarello, 2010).  
c. Full recovery from the acute systemic inflammatory response goes through the 
resolution phase which represents more than just turning off production of 
proinflammatory mediators proteins and lipids. In fact, the synthesis of a new type of 
regulatory molecules is often initiated. First, the anti-inflammatory cytokines (listed in 
Table 1) appear and gain the field by inhibiting synthesis of proinflammatory cytokines. 
The most important is probably IL-10 family showing pleiotropic immunosuppressive 
and anti-inflammatory properties (Fickensher et al., 2002). However, as pointed out by 
Cavaillon (2001) the strict dichotomy of pro- and anti-inflammatory properties is 
artificial because the biologoical effects depend considerably on the biological context 
(Scheller et al.). We found that IL-4, IL-13 and IL-10 inhibit synthesis of TNFǂ and IL-6 
in the whole blood stimulated ex vivo with LPS, but are ineffective, or even enhance 
production of IL-6 in cultured HUVEC endothelial cells (Guzdek et al., 2000). The most 
important anticytokine and antiinflammatory effects are probably exerted by 
suppressors of cytokine signaling (SOCS) and protein inhibitors of activated STATs 
(PIAS) (Ferguson & Johnston 2001; Wormald & Hilton, 2005). In Hawiger’s laboratory a 
recombinant variant of cell-penetrating SOCS3 was obtained showing some protective 
effects in animal models of inflammation (Jo et al., 2005). Among lipid-derived 
molecules produced in the resolution phase antiinflammatory properties are shown by 
lipoxins and resolvins (Table 1 and Anderson, 2010).  It should be reminded here that in 
all phases of inflammatory response complex changes in the profile of metabolic 
regulators occur on many levels - transcription, mRNA stability, translation and 
posttranslational modification of proteins (Evans, 2005).  
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The return to biological homeostasis may be facilitated and supported by pharmacological 
intervention. Traditionally used in therapy low molecular weight antiinflammatory drugs, 
such as glucocorticoids, salicylates, cyclosporin, pentoxifylline, tenidap, colchicine, statins, 
specific inhibitors of p38 MAP kinase,  and many others, are now being supplemented with 
natural macromolecular cytokine inhibitors and antagonists (reviewed in Koj, 1998; 
Dinarello 2010). Particularly promising are various commercially available chimeric 
antibodies, some  soluble cytokine receptors and constructs of designer cytokines non-
existing in nature but powerful in action (Scheller & Rose-John, 2006;  Dinarello, 2010; 
Scheller et al., 2011).  
 
Cytokines: -- Pro-inflammatory: IL-1, TNFǂ, IFN-Ǆ,  VEGF,  
    IL-12, IL-17, IL-18, IL-23, IL-33 
-- IL-6 family: IL-6, IL-11, LIF, OSM, CNTF, CT-1 
 - Anti-inflammatory: IL-4, IL-10, IL-13, 
IFNalpha,  TGFbeta, IL-1Ra, MCPIP1 
-- Chemokines: IL-8, MCP-1 
-- Cellular growth factors: FGF, EGF, VEGF 
Lipid derivatives: -- glucocorticoids 
-- prostaglandins (PGE2),  
-- leukotrienes  (LTB4) 
-- lipoxins (LXB4) 
-- resolvins (RvE1 and E2) 
Cell Adhesion Molecules -  
selectins and integrins: 
-- VCAM-1,   
-- ICAM-1  
-- E-selectin 
Components of complement, 
clotting and fibrinolysis 
pathways: 
-- more than a dozen proteins (including some clotting 
factors and plasminogen activators and inhibitors) 
Certain intracellular enzymes 
and plasma acute phase proteins :
-- superoxide dismutases (MnSOD, ZnSOD)  
-- cyclooxygenases (COX-1 and COX-2) 
-- protein kinases from the MAP family (p38, ERKs) 
-- nitric oxide synthase  (NOS) 
-- fibrinogen, CRP, SAA (and a dozen of other APPs) 
Table 1. The main players in the field of inflammation development and control 
However, apart from those just mentioned well defined autoinflammatory and autoimmune 
diseases, certain elements of inflammation can be found in various pathological processes, 
such as atherosclerosis (Libby, 2002) or neurodegenerative disorders (Glass et al., 2010). In 
this respect participation of liver in the inflammatory response is very important and only 
recently it has been fully evaluated as the source of various mediators, and especially acute 
phase proteins that fulfill various functions. 
The pioneering and elegant experiments carried out on the perfused rat liver by Miller et al., 
(1951) demonstrated that all principal proteins present in the plasma of circulating blood 
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derive – with the notable exception of immunoglobulins – from the liver. Since the rat does 
not respond to injury by increased production of C-reactive protein, Miller’s experiments 
were inconclusive and the origin of CRP remained a mystery until  Hurlimann et al., (1966) 
demonstrated incorporation of radioactive amino acids into immunologically identified CRP 
after incubation of liver preparations from injured monkeys and rabbits. Today we know 
that the main acute phase proteins in the rat belong to alpha globulins (historic aspects of 
APP synthesis have been discussed in detail  elsewhere (Kushner, 1982; Gordon & Koj, 1985; 
Koj, 2008).  
6. Molecular mechanisms of induced synthesis of acute phase proteins  
The progress in elucidating the mechanisms of liver acute phase response obtained a new 
impetus when APPs synthesis, studied both in vivo and in tissue culture, became a valuable 
model for molecular biology. After cultured liver cells became routinely used it was possible 
to conclude that the “Hepatocyte Stimulating Factor” responsible for synthesis of acute 
phase proteins is a cytokine distinct from interleukin-1 (Baumann et al., 1984) and named 
interleukin-6 (Gauldie et al., 1987). In subsequent years it was found that IL-6 is the most 
important member of a large cytokine family sharing common receptor subunit gp130 and 
showing a high degree of redundancy (Sehgal et al., 1995; Heinrich et al., 2003; Baumann, 
2003). This family includes IL-6, IL-11, leukemia inhibitory factor (LIF), oncostatin M (OSM), 
cardiotrophin-1 (CT-1), cilliary neurotrophic factor (CNTF) and some other cytokines 
(Scheller et al., 2011). Recently Liang et al., (2009) reported that IL-22, although not 
belonging to IL-6 family, can induce almost all symptoms of acute phase response in the 
liver; however, the mechanism of its action is as yet not fully understood.  
It should be emphasized here that as a rule several cytokines are involved in the regulation 
of liver-produced acute phase proteins, and on this ground at least two types of cytokines 
and corresponding APPs have been distinguished by Baumann and Gauldie (1994). Type 1 
cytokines (IL-1 and TNF families) co-operate with type 2 cytokines (IL-6 family)  in the 
induced expression of such proteins as CRP, serum amyloid A, C3 complement or alpha-1-
acid glycoprotein, all belonging to type 2 APPs. On the other hand, synthesis of  other 
proteins - human fibrinogen or rat alpha-2-macroglobulin, are stimulated only by cytokines 
of IL-6 family while the presence of IL-1 or TNF decreases the response. The balance 
between the signaling pathways induced by two types of cytokines is very delicate as 
indicated by the experiments of Uhlar & Whitehead (1999). They found that the magnitude 
of synergistic stimulation of SAA synthesis is influenced not only by cytokine 
concentrations but also by the order of addition of IL-1 and IL-6 to cultured human 
hepatoma cells. Table 2 provides examples of different classes of APPs after taking into 
account stimulation with two types of cytokines.  
Positive acute phase proteins show increased levels after treatment with the appropriate 
cytokine whereas negative APPs are decreased. Class A – increased up to 200-fold; Class B - 
increased by 2-5 fold, Class C – increased by at least 25 per cent. Class D – decreased by at 
least 25 per cent. Please note species differences. Type 1 cytokines : IL-1 or TNFa; type 2 
cytokines - IL-6 family. Abbreviations: CRP, C-reactive protein; FBG, fibrinogen; C3C, third 
component of the complement; ALB, albumin; SAA, serum amyloid A; HPT, haptoglobin; 
CEP, ceruloplasmin; TST, transthyretin (pre-albumin); A2M, alpha-2-macroglobulin; AGP, 
alpha-1-acid glycoprotein; HPX, haemopexin; TRF, transferrin. 
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Positive AP-proteins Negative APPs 
 
Class A Class B Class C Class D 
CRP /type 1 
(primates, rabbit) 
FBG / type 2 
(many species) 
C3C / type 1 
(many species) 
ALB / type 1&2 
(many species) 
SAA / type 1 
(man, mouse) 
HPT / type2      
(man) 
CEP / type 1        
(many species) 
TST / type 1 
(many species) 
 
A2M / type 2 
(rat) 
AGP / type 1      
(many species) 
HPX / type 2       
(many species) 
TRF / type 2 
(many species) 
Table 2. Classification of  selected acute phase plasma proteins based on the magnitude of 
AP-response and type of stimulating cytokine (Koj, 1985a,c).  
It should be remembered that many additional factors modulate the cytokine-induced 
change of APPs synthesis rate, the most important being glucocorticoids that act 
synergistically with IL-6, especially in the rat (Koj, 1985c; Ruminy et al., 2001). 
Synthetic inhibitors of MAP kinases  interfere with many signaling pathways (Herlaar & 
Brown, 1999; Lee et al., 2000). As shown by Westra et al., (2006) inhibition of p38 MAPK in 
cells of human hepatoma significantly reduced cytokine-induced synthesis of CRP and 
fibrinogen (but not of SAA). Among other low-molecular weight drugs statins – originally 
used for inhibition of cholesterol synthesis - were shown to possess broad anti-inflammatory 
properties (Sparrow et al., 2001) and effectively reduce certain symptoms of acute phase 
response (Munford, 2001).    
A recent report by Patel et al., (2009) indicates that the aryl hydrocarbon receptor (AHR) can 
repress cytokine-induced synthesis of APPs in mouse liver. A somewhat similar 
downregulation of the AP-response was reported by Venteclef et al., (2006) for the liver 
receptor homolog 1 (LRH-1). Overexpression of LRH-1 resulted in the inhibition of IL-1- and 
IL-6-mediated FBG, SAA, CRP and HPT gene expression. All of the genes inhibited by LRH-
1 in response to cytokine stimulation contain functional C/EBP DNA-binding sites within 
their promoter regions (Venteclef et al., 2006). Since LRH-1 was originally identified as a key 
player in cholesterol regulatory mechanisms the authors conclude that this liver orphan 
receptor could be a novel molecular link between cholesterol homeostasis and 
inflammation. Still another liver receptor, PPAR-ǂ (peroxisome proliferators-activated 
receptor-alpha), was found to attenuate the IL-6-induced synthesis of APPs (Mansouri et al., 
2008). Direct involvement of hepatic PPAR was demonstrated using a liver-restricted 
expression of PPAR in mice, while as a distal repercussion the decreased expression of 
adhesion molecules in aorta was observed. 
Development of new techniques of the genomics era, such as subtractive hybridization, 
differential display or microarrays, provided a global approach in the studies of inducible 
gene expression and synthesis of APPs. Olivier et al., (1999) described a novel set of hepatic 
mRNAs preferentially expressed during acute inflammation elicited in the rat by turpentine 
injection. When sequencing 174 selected clones these authors identified 23 already known 
AP-proteins, 31 proteins known but so far not  related to  the AP-response, and discovered 
36 novel proteins induced in the liver during turpentine-induced inflammation. More 
recently the Salier’s group  studied changes in the human liver transcriptome in patients 
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with systemic inflammation (Coulouarn et al., 2004). They found over 150  specific mRNAs 
expressed in the liver and correlating with  the extent of inflammatory processes. This 
number was increased to over 600 genes  in a model system of  human hepatoma cells 
treated with the conditioned medium from endotoxin-stimulated macrophages (Coulouarn 
et al., 2005). The kinetic analysis of transcription rate and mRNA stability led the authors to 
a very important conclusion: inflammation-induced mRNAs appear in the cells not in a 
random fashion but as consecutive transcriptional waves corresponding to functionally 
related proteins produced in an orderly fashion. 
In order to study the effects of low doses of IL-1 and/or IL-6 on human hepatoma cells 
HepG2 differential display was used in our laboratory (Wegrzyn et al., 2006). We found that 
out of 88 cDNA species modulated by IL-6 only 38 represented various known genes, 18 
clones matched genomic clones in the NCBI data with hypothetical cDNA sequences, and 
the remaining 32 clones showed no homology with databases. When the cells were 
stimulated with the mixture of IL-1 and IL-6 only 43 cDNA fragments were amplified 
suggesting the prevailing negative regulation  by IL-1. The identified transcripts modulated 
by IL-6 alone, or by both cytokines, were found to code for intracellular proteins engaged in 
general metabolism, protein synthesizing machinery and cellular signaling. 
Since macrophages are important for the development of inflammation and the acute phase 
response, many attempts have been made to discover pathogen-induced changes in these 
cells using microarrays: in our case we identified IL-1 and IL-6 responsive genes in human 
monocyte-derived macrophages using Affymetrix microarrays (Jura et al., 2008). A major 
problem encountered in our experiments aroused from individual variability of basal 
transcriptome profile among blood donors. However, out of  almost 5000 probe sets 
consistently detected in all array replicates we found more than 200 genes modulated by IL-
1 and/or IL-6, among which 34 could be regarded as novel cytokine-responsive genes of 
various functions. A detailed analysis indicated that 125 transcripts were stimulated by IL-1 
and 39 by IL-6, whereas the number of downregulated genes was similar for both cytokines 
(approximately 30  genes in each group). Among the identified IL-1 responsive genes we 
found one of particular interest, named  ZC3H12A and coding for MCPIP1, which plays a 
pivotal role in the control of inflammation. Recent experiments indicate that MCPIP1 
enhances decay of mRNAs coding for some inflammatory mediators (Mizgalska et al., 2009; 
Matsushita et al. 2009), but also interferes with NF-κB-dependent signaling pathway 
(Skalniak et al., 2009; Liang  et al., 2009). 
Last years brought abundant information on the role of microRNA in the regulation of gene 
expression – and the field of inflammation is no exception. As reported by Harris and co-
workers (2008) miRNA-126 inhibits VCAM-1 expression in HUVEC culture and thus may be 
considered as a potential drug reducing  leukocyte adherence to endothelial cells, and  in 
consequence their migration to the site of injury. 
7. Multiple biological functions of acute phase proteins 
Acute phase proteins represent the products of a large group of genes conserved during 
evolution and regulated by numerous cytokines that show considerable redundancy. This 
indicates the importance of APPs in respect of survival value for the animal organism and 
explains the origin of accepted paradigm stating that “the principal function of APPs is 
their ability to restore homeostasis disturbed by injury and inflammation (Koj, 1985b).”  
Recent years brought further support of this idea as indicated by the data presented in Table 
3, but only some of the results will be discussed here, starting from proteinase inhibitors. 
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Function  AP-proteins engaged                                                    
1. Inhibition of proteinases Macroglobulins, serpins, kininogens:- over 20 
proteins 
2. Blood clotting and 
fibrinolysis 
Fibrinogen, ǂ1proteinase inhibitor, antithrombin 
III,   
ǂ2antiplasmin, C1- inactivator, 1glycoprotein, 
serum amyloid P, C-reactive protein, kininogens 
3. Anti-inflammatory 
properties 
Proteinase inhibitors, fibrinopeptides, 
haptoglobin 
4. Removal of pathogens 
and  foreign materials 
C3 complement, C-reactive protein, serum 
amyloid A and P proteins, fibrinogen 
5. Modulation of 
immunological response
Proteinase inhibitors, C-reactive protein, ǂ2HS-
glyco-protein, C3 complement, fibrinogen 
 
6. Transport of various 
materials 
Transferrin, ceruloplasmin, transthyretin, 
haptoglobin,  
hemopexin, ǂ1glycoprotein, macroglobulins, 
albumin 
Table 3. Selected examples of homeostatic functions of APPs  
Human plasma contains at least ten distinct and well characterized proteins responsible for 
the inhibition of various serine-, cysteine-, aspartic- and metalloproteinases. The list of 
inhibitors includes: alpha-2-macrogloblin(A2M), alpha-1-proteinase inhibitor (API), alpha-1-
antichymotrypsin (ACT), inter-alpha trypsin inhibitor (ITI), antithrombin III (AT3), C-1-
inactivator (C1N), alpha-2-antiplasmin(APL), beta-1-anticollagenase (BAC) and high and 
low molecular weight kininogens (HMK and LMK, both able to inhibit cysteine 
proteinases). Among those ten inhibitors the most important are: API and ACT (both being 
strong acute phase reactants in man), and A2M (a spectacular APP in the rat). 
The dynamic equilibrium between the blood or tissue proteinases and their natural 
inhibitors is drastically disturbed during acute inflammation (Koj et al., 1993). A massive 
release of proteolytic enzymes from injured tissues and infiltrating leukocytes or 
macrophages should be promptly neutralized by a range of antiproteases present in body 
fluids. Since the reaction between proteinases and inhibitors is in most cases  irreversible, 
and the resulting complexes are  removed, the enhanced proteolytic activity could seriously 
deplete the body reserves of these antiproteases. As demonstrated by many authors such 
situation occurs in certain cases of acute pancreatitis and in septic shock. However, the acute 
phase response usually facilitates replenishment of proteinase inhibitors  due to their 
enhanced liver synthesis. In human hepatoma cells the expression of API and ACT is 
stimulated primarily by IL-6 whereas A2M synthesis in man (in distinction to the rat) is 
enhanced by IFNgamma (Kordula et al., 1992).  
The macroglobulin family of proteinase inhibitors comprises a large group of proteins 
characterized by a broad specificity due to the presence of a characteristic bait region 
whereas irreversible binding of the enzyme requires a labile thiol ester. The entrapped 
proteinase may show still some activity toward small molecular weight substrates. Synthesis 
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of alpha-2-macroglobulin in the rat is greatly stimulated during inflammation whereas 
alpha-1 macroglobulin does not change significantly – and these two macroglobulins have 
different specificity in respect of proteinase inhibition (Tsuji et al., 1994).  
The members of serine proteinase inhibitors named serpins, show considerable variations 
in their strict specificity  toward the target enzymes. API (initially named antitrypsin) 
inhibits also leukocyte elastases, whereas ACT blocks leukocytic cathepsin G. A 
charactertistic structural feature of all serpins is the existence of an exposed peptide loop 
which in the native form is in the strained position being replaced to a stable configuration 
by proteolytic attack. Recently it was found that two hormone-transporting proteins – 
thyroxin-binding globulin and cortisol-binding globulin, belong also to the serpin 
superfamily. Although they do not show detectable antiprotease activity, their molecules 
contain a characteristic polypeptide loop easily cleaved by proteinases (Pemberton et al., 
1995). After cleavage of cortisol-binding protein by neutrophil elastase a tenfold decrease of 
affinity for cortisol was observed. In that way cortisol may be delivered preferentially to the 
inflammation site abounding in serine proteinases of leukocyte origin. 
Rats appear to be unique in their ability to produce considerable amounts of thiostatin - an 
inhibitor of cysteine proteinases (known formerly as alpha-1-acute phase globulin, or rat 
major acute phase globulin). In fact  thiostatin is a special type of kininogen releasing 
biologically active kinins upon treatment with trypsin-like enzymes (Lalmanach et al., 2010). 
Thiostatin is able to inhibit calpain, papain and cathepsin L.  
As already mentioned, plasma proteinase inhibitors may fulfill some additional functions 
apart from the removal of specific enzymes. Thus it has been shown that macroglobulins 
bind highly toxic eosinophil cationic proteins, are involved in the transport of cellular 
growth factors and may reduce the effects of endotoxin-induced shock, but are also able to 
modulate immunological response: it was reported that API, ACT and A2M inhibit the 
activity of natural killer cells and reduce the antibody-dependent cell-mediated cytotoxicity 
(Ades et al., 1982). 
Recent years brought abundant information on the role of some APPs in the modulation of 
immunological response, removal of pathogens or foreign materials and reduced 
inflammation. Pentraxins are multimeric proteins including “short pentraxins” (CRP and 
SAP produced in hepatocytes), and “long pentraxins” (PTX3 synthesized in macrophages, 
fibroblasts and in activated endothelium) (Szyper-Kravitz, 2006; Mantovani et al., 2008). All 
pentraxins fulfill the function of soluble pattern recognition receptors interacting with 
certain bacterial pathogens and with surface of apoptotic cells thus playing an important 
role in the removal of cell debris.  Moreover, CRP and SAP bind and activate certain 
complement components important for the innate immunity. This may have negative effects 
in some diseases: it is known that during incipient heart infarct human CRP strongly 
activates complement cascade at the site of ischaemia thus enhancing tissue injury. Pepys 
and co-workers (2006) recommend to reduce the increased level of newly synthesized CRP 
by giving to a patient derivatives of phosphatidyl choline,  known to be a good competitive 
ligand for CRP. 
Besides pentraxins, mannose-binding lectin (MBL) and apolipoprotein A1 belong to 
protective molecules (Szyper-Kravitz, 2005). They are produced in hepatocytes but ApoA1 is 
a negative APP and MBL level is not affected by cytokines. Szyper-Kravitz et al., (2005) 
suggest that  the discussed pentraxins, as well as  MBL and ApoA1, are important for 
autoimmune diseases and thus are often used - along with CRP – as clinical markers of 
progression of inflammation.  
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Serum amyloid A (SAA) is a strongly induced and a well known AP-protein in man and 
mouse but recently Cheng et al., (2008) and He and co-workers (2009) made original 
observations. According to Cheng TLR2 is a functional receptor for SAA and its stimulation 
leads to enhanced activity of NF-κB that is accompanied by increased phosphorylation of 
MAPKs and accelerated degradation of IkBalpha. In this way SAA may affect the course of 
AP response and some inflammatory diseases. He and co-workers demonstrated that SAA 
is a potent endogenous inducer of granulocyte colony-stimulating factor (G-CSF) 
responsible for neutrophilia. This effect of SAA is dependent on Toll-like receptor TLR2. 
As indicated by the results of Kramer et al., (2010) some APPs or their proteolytic fragments 
are involved in the earliest antiviral response in HIV-1 infection. The active components 
were identified as serum amyloid A and a peptide derived from alpha-1-proteinase 
inhibitor. Insights gained into the mechanism of action of acute phase reactants against HIV 
could be exploited for the development of prophylactic vaccine strategies. 
 The broadest conclusions on the homeostatic potential of APPs derive from the studies of 
Sander and Trautwein, (2010). They used an original global approach based on the fact that 
liver AP-response critically depends on gp130 subunit of the membrane-bound receptor of 
IL-6 family of cytokines, and subsequent interaction of gp130 with STAT3 transcription 
factor. By creating mice deficient in this receptor the authors blocked induced synthesis of 
APPs and this strongly increased the mortality of mice in a model of polymicrobial sepsis. 
Further experiments showed that hepatic gp130-STAT3 interaction was also essential for 
mobilization and tissue accumulation of myeloid-derived suppressor cells (MDSC), a cell 
population known from their anti-inflammatory properties in cancer. The authors identified 
two hepatocyte-produced proteins - serum amyloid A and Cxcl1/KC chemokine - as 
cooperatively promoting MDSC mobilization. They concluded that  gp130 dependent 
communication between the liver and MDSCs through some APPs controls the 
inflammatory responses in the infected mice. The discussed results are related to the new 
function of SAA as an endogenous TLR2 ligand (Cheng et al., 2008). 
8. Concluding remarks 
Elucidation of molecular events concerning the initiation and development of inflammatory 
reaction has progressed considerably during the last 10 years. The membrane-bound and 
cytosolic receptors recognizing pathogen-associated - or stress-associated - molecular 
patterns deriving either from invading pathogens or from damaged cells, have been 
identified. These signals generated by stimulated receptors lead to assembly of 
inflammasomes - molecular platforms activating the main proinflammatory cytokine – 
interleukin-1. Then IL-1 and other cytokines utilize the multistep signaling cascades to 
activate the pivotal transcription factor NF-κB subsequently translocated to the nucleus. 
There, in cooperation with other TFs, NF-κB  initiates transcription of hundreds of genes 
coding for various proteins participating in inflammation. This process is tightly regulated 
and properly tuned due to cooperation of many different transcription factors and 
subsequent stabilization or enhanced decay of specific mRNAs in exosomes. Recent studies 
led to identification of a new multifunctional regulatory protein MCPIP1, which can affect 
both mRNA stability and NF-κB signaling. Although the inflammatory response may occur 
in various forms, particularly important for the final outcome is the liver acute phase 
response regulated mainly by IL-6 family of cytokines. The liver-produced acute phase 
proteins exhibit multiple functions important for restoring homeostasis disturbed by injury 
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and inflammation. Particularly interesting are new data on APPs classified as proteinase 
inhibitors from three families (macroglobulins, serpins and thiostatins) and original findings 
on the role of protective molecules belonging to pentraxins and serum amyloid A protein. 
These discoveries create chances for new therapeutic strategies concerning the treatment of 
septic shock syndrome and chronic autoimmune or autoinflammatory diseases.  
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